- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06771765
Soup Meal Satiety Study
Satiety Promoting Effects of Chia and Hemp Seeds
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
STUDY DESIGN
This study will be a randomized crossover with three treatment periods. Subjects (n=24, approximately equal number of men and women) will be randomly assigned to a treatment sequence.
There will be three 2-day treatment periods separated by a break of ~0-4 weeks, depending on calendar conflicts such as holidays. The treatment period diets will differ in the inclusion of seeds into the recipes on the second day of each period. For all meals on Day 1 and breakfast & lunch on Day 2 of each treatment period, participants will consume a prescribed diet provided by the Beltsville Human Nutrition Research Center. The Day 1 meals and the Day 2 breakfast will be the same for each treatment period (scaled to each participant's intake needs for weight maintenance) so that the participants will be in the same food consumption state the day before the test day. Day 2 lunch will be the treatment meal and will consist of soup, bread, and a dessert item (cookie or brownie). Each of those treatment items (soup, bread, and dessert) will be made one of three ways: (1) by our standard recipe, (2) by our standard recipe modified to include chia seeds, or (3) by our standard recipe modified to include hemp seeds. Dinner on Day 2 will be provided for carry-out and will include a large serving of a dinner entrée, a dessert, and a snack. The Day 2 dinner foods will be provided in excess, and participants will be allowed to eat as much or as little as they like, and they will bring the uneaten portions back to the Beltsville Human Nutrition Research Center the next morning, at which time they will be given a light breakfast, ending the treatment period. The Day 2 dinner items will be weighed before and after the participants eat, and the amount consumed will be recorded and compared across the different recipes to determine if the inclusion of seeds in the recipe promoted satiety. Water will be allowed ad libitum, except that consumption of liquids will not be allowed for the hour before lunch and the hour before dinner on Day 2 of each treatment period.
Participants will complete a series of hunger, fullness, food, and mood related questionnaires during the study.
STUDY PROCEDURES
Controlled feeding intervention: The Beltsville Human Nutrition Research Center will provide all meals to subjects during each 2-day treatment period. Meals will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet. For meals on Day 1 and breakfast & lunch on Day 2 of each treatment period, participants will be instructed to eat all foods and only foods provided to them, with the exception of water, coffee, and tea. Coffee and tea intake will be limited to 2 cups per day. Consumption of coffee, tea, and water will be recorded by study subjects. Dinner and snack food for Day 2 of each treatment period will be provided in excess (about 3 times the participants expected calorie needs) and the participants will consume as much or as little of those foods as they like, but they will not be allowed to consume any other foods beyond the foods provided. Alcohol consumption will not be allowed during the intervention.
Body weight: Body weight will be measured at the beginning of each treatment period.
Questionnaires: Participants will be asked to complete a series of questionnaires.
- Participants will complete a questionnaire each study day (6 days total) with questions regarding general health, medications, exercise, and beverage consumption.
- Participants will complete a Three-Factor Eating Inventory on the first morning of the first study session to determine if they are restrained eaters.
- Participants will complete a Positive and Negative Affect Schedule questionnaire before dinner on the second day of each study session to determine if mood states are different among the three study sessions.
- Participants will complete a Visual Analogue Scale assessment of the following subjective feelings at the moment of the assessment: (1) Hunger, (2) Satisfaction, (3) Fullness, (4) Prospective Food Consumption, (5) Desire to Eat something sweet, salty, savory, or fatty. This assessment will be completed on Day 2 of each session, at the following times: immediately before lunch, immediately after lunch, 1 hour after lunch, 2 hours after lunch, 3 hours after lunch, 4 hours after lunch, 5 hours after lunch, and 6 hours after lunch (which will be about 30 minutes after finishing dinner).
Food Intake: Using an analytical scale, Day 2 dinner foods for each participant will be weighed before they are provided to the participants and after the uneaten foods are returned to the Beltsville Human Nutrition Research Center. The weight of the foods will be recorded.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Beltsville, Maryland, United States, 20705
- U.S. Department of Agriculture, Beltsville Human Nutrition Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
-
Exclusion Criteria:
- Younger than 25 years
- Known (self-reported) allergy or adverse reaction to study foods
- Women who have given birth during the previous 12 months or who are pregnant/lactating or who plan to become pregnant over the upcoming 6 months (thus during the study period)
- Presence of diabetes, diverticulitis, colitis, celiac disease, Crohn's disease, irritable bowel syndrome, gastrointestinal disease, pancreatic disease
- History of bariatric surgery or other weight control surgery
- Removal of a portion of the stomach or gastrointestinal tract
- Actively trying to gain or lose weight at the time of the study recruitment or planning to gain or lose weight during the study periods
- Diminished sense of taste and/or smell
- Anorexia Nervosa and/or Bulimia
- Smoking, vaping, or use of tobacco products in the past 3 months
- Suspected or known physiological/mechanical GI obstruction
- Use of certain medications or supplements (prescription or over-the-counter) that may interfere with the study objectives
- Unable or unwilling to give informed consent or communicate with study staff
- Self-report of alcohol or substance abuse within the past 12 months and/or current treatment for these problems (long-term participation in Alcoholics Anonymous is not an exclusion)
- Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control Lunch Meal
A lunch meal will be provided that is comprised of soup, bread, and a cookie.
These items will be made from standard recipes.
This arm will be a placebo comparator to meals made with chia seeds or hemp seeds, which may provide extra satiety.
|
This intervention is a lunch meal made from standard recipes.
This intervention is the placebo control intervention.
|
|
Experimental: Chia Enriched Lunch Meal
A lunch meal will be provided that is comprised of soup, bread, and a cookie.
These items will be made from standard recipes that have been enhanced with chia seeds, which may provide extra satiety compared to the standard recipes in the placebo arm.
|
Chia seeds will be added to soup, bread, and a cookie, and these food items will be served as a lunch meal.
|
|
Experimental: Hemp Enriched Lunch Meal
A lunch meal will be provided that is comprised of soup, bread, and a cookie.
These items will be made from standard recipes that have been enhanced with hemp seeds, which may provide extra satiety compared to the standard recipes in the placebo arm.
|
Hemp seeds will be added to soup, bread, and a cookie, and these food items will be served as a lunch meal.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Desire to Eat
Time Frame: 0, 1, 2, 3, 4, 5, and 6 hours post treatment
|
Area Under the Curve for Visual Analogue Scale Assessment of Desire to Eat versus Time
|
0, 1, 2, 3, 4, 5, and 6 hours post treatment
|
|
Dinner Food Intake
Time Frame: 5 hours post intervention
|
Weight of food eaten at dinner
|
5 hours post intervention
|
|
Feelings of Hunger
Time Frame: 0, 1, 2, 3, 4, 5, and 6 hours post treatment
|
Area Under the Curve for Visual Analogue Scale Assessment of Hunger versus Time
|
0, 1, 2, 3, 4, 5, and 6 hours post treatment
|
|
Feelings of Satisfaction
Time Frame: 0, 1, 2, 3, 4, 5, and 6 hours post treatment
|
Area Under the Curve for Visual Analogue Scale Assessment of Satisfaction versus Time
|
0, 1, 2, 3, 4, 5, and 6 hours post treatment
|
|
Feelings of Fullness
Time Frame: 0, 1, 2, 3, 4, 5, and 6 hours post treatment
|
Area Under the Curve for Visual Analogue Scale Assessment of Fullness versus Time
|
0, 1, 2, 3, 4, 5, and 6 hours post treatment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Janet Novotny, PhD, United States Department of Agriculture (USDA)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity Prevention
-
Augusta UniversityEnrolling by invitationObesity PreventionUnited States
-
Amsterdam University Medical Centers (UMC), Location...RecruitingObesity Prevention | Microbiome AnalysisNetherlands
-
Northwell HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPrevention Childhood Obesity | Feasibility and AcceptabilityUnited States
-
Marie HERRCompletedObesity Prevention | Cancer PreventionFrance
-
University of TorontoThe Hospital for Sick Children; Dairy Farmers of CanadaCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoNatural Sciences and Engineering Research Council, Canada; Mondelēz International... and other collaboratorsCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoNatural Sciences and Engineering Research Council, Canada; Mondelēz International...CompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoIngredion IncorporatedCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoIngredion IncorporatedCompletedDiabetes Prevention | Obesity PreventionCanada
-
Centre d'Etudes et de Documentation du SucreMinistry of Higher Education and Research, France; Paris Academy (Rectorat... and other collaboratorsCompletedPrimary Prevention | Obesity Prevention | Body Weight ControlFrance
Clinical Trials on Control (placebo) group
-
University of PernambucoUnknown
-
The Fourth Affiliated Hospital of Zhejiang University...Not yet recruitingCerebral Infarction Recovery | Rehabilitation Treatment | Upper Extremity Motor Function | Emg BiofeedbackChina
-
The Hong Kong Polytechnic UniversityCompleted
-
Pusan National University Yangsan HospitalCompletedDyspepsiaKorea, Republic of
-
Inonu UniversityNot yet recruitingPregnancy | Preeclampsia | Nursing Care | Augmented RealityTurkey
-
TotipotentRX Cell Therapy Pvt. Ltd.TotipotentRX CorporationUnknownAcute Myocardial InfarctionIndia
-
University of PalermoCompletedGlucose Metabolism Disorders | Bone Resorption | Hepatic Steatosis | Nutrition, Healthy | Dietary Deficiency | Lipid Metabolism DisorderItaly
-
University Medical Centre LjubljanaCompletedRecovery | Physical Fitness | Sport | Performance Enhancing Product UseSerbia
-
University of Kansas Medical CenterCompleted
-
University of Nove de JulhoWithdrawnNasal Fracture